EUVIMEDEUVIMED entdecken
Crossref

Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer

Jieru Li, Yiwei Dai, Tao Wang, Xinyu Zhang, Pengcheng Du, Yuman Dong, Zuoyi Jiao

Journal of Controlled Release · 2025-04 · 380 · 615-629

DOI: 10.1016/j.jconrel.2025.02.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025-04. Verfasst von Jieru Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China; Biobank of Tumors from Plateau of Gansu Province, The Secon…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Polyphenols, Nanoparticles, Docetaxel. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Science and Technology Department of Gansu Province, Fundamental Research Funds for the Central Universities, Gansu Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is challenging to treat due to its difficulty in early diagnosis, highly invasive nature, and high metastatic potential. Currently, the primary treatments for PDAC are chemotherapy and immunotherapy. However, the abundance of extracellular matrix and immunosuppressive cells in the tumor microenvironment (TME) severely impedes the effectiveness of chemotherapy and immunotherapy, promoting tumor growth and metastasis. Indoleamine 2,3-dioxygenase 1 (IDO1), an immunosuppressive tryptophan-metabolizing enzyme, is upregulated in PDAC and degrades tryptophan (Trp) into kynurenine (Kyn), which is toxic to effector T cells and induces regulatory T cells (Treg) recruitment. Herein, we propose a concise strategy to construct a biocompatible, polyphenol-based, pH-responsive nanoparticle to co-deliver docetaxel (DTX) and NLG919 (an IDO1 inhibitor) to significantly enhance chemo-immunotherapy for PDAC by remodeling the TME. The DTX/NLG919-loaded nanoparticles (FPND) effectively elicited immunogenic cell death (ICD) in PDAC cells while limiting immunosuppressive Kyn production through IDO1 inhibition. FPND triggered an effective anti-tumor immune response, characterized by increased CD8+ T cells infiltration and decreased Treg recruitment, leading to significant inhibition of subcutaneous tumor growth in KPC mice through a combination of chemotherapy and immunotherapy. Overall, FPND nanoparticles showed excellent anti-tumor efficacy as a PDAC therapeutic strategy with broad potential in precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsPolyphenolsNanoparticlesDocetaxelAntineoplastic AgentsCarcinoma, Pancreatic DuctalAnimalsHumansIndoleamine-Pyrrole 2,3,-DioxygenaseImmunotherapyHydrogen-Ion ConcentrationCell Line, TumorMiceTumor MicroenvironmentMice, Inbred C57BLFemaleImidazolesIsoindoles

Stichwörter der Autor:innen

Chemo-immunotherapyIDO1 inhibitionImmunogenic cell deathImmunosuppressive tumor microenvironmentPancreatic ductal adenocarcinoma

Substanzen

PolyphenolsIndoleamine-Pyrrole 2,3,-DioxygenaseDocetaxel1-cyclohexyl-2-(5H-imidazo(5,1-a)isoindol-5-yl)ethanolAntineoplastic AgentsImidazolesIsoindoles

Autor:innen und Institutionen

  • The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China; Biobank of Tumors from Plateau of Gansu Province, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 7300…
  • College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, China.
  • Biobank of Tumors from Plateau of Gansu Province, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China; Cuiying Biomedical Research Center, The Second Hospital & Clinical Medical Scho…

Förderung

  • Science and Technology Department of Gansu Province
  • Fundamental Research Funds for the Central Universities
  • Gansu Provincial Natural Science Foundation
  • Liuzhou Science and Technology Project
  • Lanzhou University Second Hospital
  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Dai, Y., Wang, T., Zhang, X., Du, P., Dong, Y., & Jiao, Z. (2025). Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer. Journal of Controlled Release, 380, 615-629. https://doi.org/10.1016/j.jconrel.2025.02.021

Vancouver

Li J, Dai Y, Wang T, Zhang X, Du P, Dong Y, et al. Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer. Journal of Controlled Release. 2025;380:615-629. doi:10.1016/j.jconrel.2025.02.021

BibTeX
@article{Li2025,
  author = {Li, Jieru and Dai, Yiwei and Wang, Tao and Zhang, Xinyu and Du, Pengcheng and Dong, Yuman and Jiao, Zuoyi},
  title = {Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer},
  journal = {Journal of Controlled Release},
  year = {2025},
  volume = {380},
  pages = {615--629},
  doi = {10.1016/j.jconrel.2025.02.021}
}
Kostenlos starten →